LON:SALV SalvaRx Group (SALV) Share Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free SALV Stock Alerts GBX 4.50 0.00 (0.00%) (As of 12/19/2019) Add Compare Share Share Today's Range 4.50▼ 7.9050-Day Range 4.50▼ 4.5052-Week Range 4.50▼ 7.90Volume50,758 shsAverage Volume50,758 shsMarket Capitalization£1.65 millionP/E Ratio0.03Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get SalvaRx Group alerts: Email Address Ad Stansberry ResearchWorld’s biggest multibillionaire investor is buying THIS by the ton [picture]Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. About SalvaRx GroupSalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.Read More SALV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SALV Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive SALV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SalvaRx Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SALV Previous SymbolLON:3LEG CUSIPN/A CIKN/A Webwww.salvarx.io Phone+44-1624-811611FaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio0.03 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio14.50 Current Ratio1.89 Quick Ratio1.89 Sales & Book Value Annual Sales£64.50 million Price / Sales0.03 Cash FlowGBX 1.29 per share Price / Cash Flow3.50 Book ValueGBX 15.40 per share Price / Book0.29Miscellaneous Outstanding Shares36,700,000Free FloatN/AMarket Cap£1.65 million OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Denham Hervey Newall Eke (Age 67)CFO & Director Key CompetitorsNuformixLON:NFXPhysiomicsLON:PYCReNeuron GroupLON:RENEEvgen PharmaLON:EVGPort Erin Biopharma InvestmentsLON:PEBIView All Competitors SALV Stock Analysis - Frequently Asked Questions How have SALV shares performed in 2024? SalvaRx Group's stock was trading at GBX 4.50 at the beginning of the year. Since then, SALV stock has increased by 0.0% and is now trading at GBX 4.50. View the best growth stocks for 2024 here. What other stocks do shareholders of SalvaRx Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other SalvaRx Group investors own include Premier African Minerals (PREM), Cradle Arc (CRA), Cora Gold (CORA), Big Sofa Technologies Group (BST), Bahamas Petroleum (BPC), Bacanora Lithium (BCN), AutoZone (AZO), Angus Energy (ANGS), Allergy Therapeutics (AGY) and AFR.L (AFR). How do I buy shares of SalvaRx Group? Shares of SALV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SALV) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SalvaRx Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.